Sunesis Pharmaceuticals, Inc. (NASDAQ:SNSS) Pric

Sunesis Pharmaceuticals, Inc. (NASDAQ:SNSS) Price Target Update
Frank Rogers August 28, 2015

Sunesis Pharmaceuticals, Inc. (NASDAQ:SNSS) stock has received a short term price target of $ 1.9 from 5 Analyst. The share price can be expected to fluctuate from the mean short term target, can be seen from the standard deviation reading of $0.74. The higher estimate of target price is $3 , while the lower price target estimate is $1

Sunesis Pharmaceuticals, Inc. (NASDAQ:SNSS) has received a short term rating of hold from research analysts at Zacks with a rank of 3. The company has been rated an average of 3.57 by 7 Wall Street Analysts. 5 broker firms have advised hold. 2 market experts have rated it as strong sell.

Sunesis Pharmaceuticals, Inc. has lost 5.78% in the last five trading days and dropped 20.3% in the last 4 weeks. Sunesis Pharmaceuticals, Inc. has dropped 55.27% during the last 3-month period . Year-to-Date the stock performance stands at -58.43%.

Many analysts have commented on the company rating. Major Brokerage house, Cowen & Company downgrades its ratings on Sunesis Pharmaceuticals, Inc. (NASDAQ:SNSS). According to the information available, the shares are now rated Market Perform by the analysts at the agency. Previously, the analysts had a Outperform rating on the shares. The rating by the firm was issued on July 24, 2015.

Currently the company Insiders own 0.5% of Sunesis Pharmaceuticals, Inc. Company shares. In the past six months, there is a change of -61.83% in the total insider ownership. Institutional Investors own 69.1% of Company shares. During last 3 month period, -2.42% of total institutional ownership has changed in the company shares. On a different note, The Company has disclosed insider buying and selling activities to the Securities Exchange, Swisher Daniel N Jr, CEO of Sunesis Pharmaceuticals Inc, had purchased 25,000 shares on July 24, 2015. The total value of the transaction was $25,500. The information was disclosed with the SEC in a Form 4 Filing. The information is based on open market trades at the market prices.Option exercises are not covered.

Sunesis Pharmaceuticals, Inc. (NASDAQ:SNSS) : On Thursday heightened volatility was witnessed in Sunesis Pharmaceuticals, Inc. (NASDAQ:SNSS) which led to swings in the share price. The shares opened for trading at $1.08 and hit $1.1 on the upside , eventually ending the session at $1.06, with a gain of 2.91% or 0.03 points. The heightened volatility saw the trading volume jump to 904,784 shares. The 52-week high of the share price is $8.455 and the company has a market cap of $80 million. The 52-week low of the share price is at $0.84 .

Sunesis Pharmaceuticals, Inc. (Sunesis) is a biopharmaceutical company focused on the development and commercialization of oncology therapeutics for the treatment of solid and hematologic cancers. The Company is focuses primarily on the development of vosaroxin for the treatment of acute myeloid leukemia (AML). Vosaroxin is a anti-cancer quinolone derivative (AQD). AQDs have been shown to mediate anti-tumor activity by targeting mammalian topoisomerase II, an enzyme critical for cell replication. The Company owns worldwide development and commercialization rights to vosaroxin. The Companys VALOR trial is designed to evaluate the effect of vosaroxin in combination with cytarabine, chemotherapy in AML. The trial has an adaptive design and is based on data from the Companys Phase II clinical trial of vosaroxin in combination with cytarabine in relapsed or refractory AML.

I'm in it to win it!

NASDAQ DIP and RIP
Here is the best word that describes what i do here.
Intuitive;
means having the ability to understand or know something without any direct evidence or reasoning process.

I was born with it, I'm truly blessed!

Alway's searching for winners'